Thursday, June 7, 2012

I-502's DUI Provision: A Look At The Facts And FAQs

One
of the most controversial provisions of New Approach Washington’s
I-502 is its per se DUI limit of 5 nanograms of active THC metabolite
per milliliter of blood. It's a limit that some critics have dubbed
“unscientific” and “draconian.” Others claim that it is not a
measure of impairment and would threaten the driving rights of every
medical cannabis patient in Washington State.

These
are serious criticisms. So how does New Approach Washington defend
its 5 nanogram provision?

When
502 was filed with the Secretary of State's office in June 2011, the
New Approach Washington website listed one study to justify the 5
nanogram limit. It was a meta-study (or survey) of many dozens of
currently existing studies and was authored by Grotenhermen, Leson and others. Here's what NAW said of the study at the time:

A
meta-analysis of 90 experimental studies of the impact of smoked and
oral marijuana on driving, and comparison with the results of a
meta-analysis on alcohol and driving, suggest that a THC
concentration of 5 ng/mL whole blood corresponds approximately to
0.08 BAC.

What
did the study itself say? It's a lengthy study and it made many
interesting observations, including this telling one:

The
crash risk apparently begins to exceed that of sober drivers as THC
concentrations in whole blood reach 5–10 ng/mL (corresponding to
about 10–20 ng/mL in blood serum or plasma). Because recent studies
involved only a few drivers with THC concentrations in that critical
range, a reliable assessment of
the associated crash risk is still lacking.

Translation:
scientists think there's some statistical noise between active THC
concentrations of 5 to 10 nanograms, but there's not enough evidence
to reach firm conclusions. It's telling that NAW no longer includes
the claim that the above study asserts that 5 nanograms “corresponds
approximately to 0.08 BAC” on its DUI FAQ sheet.

Instead,
NAW now uses the same Grotenhermen study to back its assertion on its
FAQ sheet that “THC impairs driving skills, and the impairment can
last for a few hours after smoking or consuming marijuana.”
This, despite the fact that the same exact study states, as I quoted
above, “a reliable assessment of the associated crash risk is still
lacking.”

NAW's
DUI FAQ sheet now leans heavily upon yet another meta-study from which the 502 group plucks a graph showing that
automobile crash risk begins to double at 5 nanograms of active THC
metabolite. But in using this graph, NAW is being deceptive.

The
5 ngs doubles crash risk figure touted by NAW is taken from crash
data gathered in Australia. A graph of the data is reproduced on
NAW's DUI FAQ sheet and the group claims “Studies of marijuana use
and driving suggest that THC levels exceeding 5 ng/mL are associated
with increased risk of accidents.”

Why
would data from Australian drivers be used to impose DUI limits on
American drivers? I don't even have a guess, but it does strike me as
highly unusual to impose driving standards on an American state based
upon crash results from an entirely different country with different
driving standards—in Oz, they drive on the other side of the road,
after all—and what is likely to be a different driving culture.

Besides,
this same meta-study—which examines a dizzying range of
studies—also points to many studies that show no link (or weak links) between
cannabis use and accidents. NAW simply chose to pick one single study
from one single section of the meta-study to buttress its case for 5
nanograms. Picking evidence in this fashion is not a good way to set public policy,
especially when one of the final points of the study is this:

Overall,
though, case-control and culpability studies have been inconclusive,
a determination reached by several other recent reviewers. Similar
disagreement has never existed in the literature on alcohol use and
crash risk.

(BTW,
an interesting fact that I ran across recently is that a Canadian study finds a 70 percent increase--so almost a doubling of crash
risk--in the risk of traffic accidents when it is raining. Do we
automatically hand drivers a DUI for driving in the rain? Do we call
them impaired because they are driving in the rain? Of course not.)

NAW
also uses one other study to support its 5 nanogram limit. It's a
study by a National Institute on Drug Abuse researcher named Erin
Karschner. In it, 25 chronic daily cannabis users were put into a
locked facility and abstained from cannabis use for seven days. Their
blood levels were taken at regular intervals to measure for active
THC metabolite among other things. NAW uses this study to assert that
“Even heavy marijuana users like medical marijuana patients should
have their THC levels drop below

5
ng/mL if they wait a few hours before driving.”

But
that's not an accurate representation of what the study concluded.
Here's what Karschner wrote:

And
here's another finding from the study that NAW fails to mention and
it's something that should make most frequent cannabis users feel
real concern:

For
the first time to our knowledge, negative whole blood specimens were
found interspersed between positive samples.

In
other words, some of the study subjects would test positive for THC
metabolite on admission to the study and then test negative a bit
later—only to test positive again after that. Regardless of the
reason for such fluctuations or at what nanogram level they occur,
how can NAW claim measuring active THC metabolite is an appropriate
measure of anything, much less impairment, when its presence varies
so widely? Would jurors believe a prosecutor who said a set of
fingerprints matched a suspect one day, but then didn't the next day,
until they were tested a third time when they again matched? Probably
not.

And,
in case you were wondering, that positive-negative fluctuation has
been confirmed by a second study, one I'll soon discuss.

It
is clear from a hard look at NAW's defense of its 5 nanogram limit
that it is playing loose with the facts and cherry-picking studies in
order to justify this provision. Is that any way to appropriately set
public policy?

2 comments:

You have to look at the bigger picture. What I-502 does is send a message to the Feds to reclassify cannabis from a schedule 1 to something lesser. We all know if I-502 passes it will get tied up in courts anyways by the Feds. The DUI portion which isn't popular can always be amended later. I believe after a bill passes you can amend after 2 years. More importantly, until we reclassify cannabis from a schedule 1 to a lesser classification it won't matter. I-502 is a vehicle to making this happen.